Research involving hepatocellular carcinoma (HCC) [72,73,74], gastric cancer [75], melanoma [76], multiple myeloma [77] and other malignancies [78] demonstrated a positive association between IL-1β levels and PD-L1 expression. This evidence concerns the gene IL1B and melanoma.